GENB

Generate Biomedicines
$15.38
+$2.17 (+16.43%)Oct 28, 2026
Return+21.6%5YRange $11.21 - $20.38
$21.5$17.7$13.9$10.1Feb 26Jun 26Oct 26

Key metrics

The numbers that frame GENB today
Market cap
$1.97B
Div yield
0%
Debt / equity
0.1

GENB stock rating

How GENB scores on quality, value, growth, momentum and financial health
-out of 10
No overall ratingBusiness strength unclear, valuation unclear
Quality-
Growth-
Momentum-
Value-
Financial Health3.2

Growth

Revenue and earnings trend for GENB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about GENB
What is the market capitalization of GENB?
Generate Biomedicines's market capitalization is $1.97B.
Does GENB stock pay dividends?
Generate Biomedicines does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GENB?
Generate Biomedicines's Debt / Equity ratio is 0.14.